Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 72, Issue 7

Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy No Access

Abstract

Serological screening and seroprevalence data for TORCH infections represent a key instrument to estimate immunity and vaccination levels and exposure rates to prevent and treat TORCH congenital infections.

Serology allows us to identify women susceptible to primary infection.

Assess the prevalence of women at risk of primary infections by TORCH pathogens in Palermo, Sicily, Italy, in the decade 2012–2022.

A retrospective study was performed to evaluate the serological status (IgG and/or IgM) of 2359 women of childbearing age (WCBA), ranging from 16 to 46 years, attending the AOUP ‘P. Giaccone’ University Hospital of Palermo.

The results showed an overall prevalence of anti-TORCH IgG of 90.5 % for herpesvirus (HSV), 81.2 % for rubella virus (RV), 72.1 % for cytomegalovirus (CMV), 20.9 % for (TOX) and 4.8 % for (TP). IgM positivity was 16.9 % for HSV2, 10.3 % for TOX, 4 % for CMV and, 2 % for RV. A recent/active infection by TP was confirmed in 28.3 % of the seropositive women. Our results indicate that only a small percentage of WCBA were subjected to a comprehensive TORCH serological screening, while most WCBA were only tested for a single pathogen. In addition, no significant differences were found in terms of the overall TORCH IgG seroprevalence among different age groups (>0.05).

Identifying WCBA at risk of exposure during pregnancy allows us to prevent and reduce possible congenital infections, providing detailed guidelines and instructions. The results of this study showed that in Italy the risk of acquiring a primary infection by a TORCH agent is still high, therefore effective prevention strategies, including serological screening, should be implemented.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): childbearing age , Italy , seroprevalence , TORCH and women
Funding
This study was supported by the:
  • Ministero dell’Istruzione, dell’Università e della Ricerca (Award Fondo Finalizzato alla Ricerca di ateneo (FFR) 2018-2020 and 2021.)
    • Principle Award Recipient: SimonaDe Grazia
© 2023 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001733
2023-07-17
2025-01-23
Loading full text...

Full text loading...

References

  1. Kishore J, Misra R, Paisal A, Pradeep Y. Adverse reproductive outcome induced by parvovirus B19 and TORCH infections in women with high-risk pregnancy. J Infect Dev Ctries 2011; 5:868–873 [View Article] [PubMed]
     [Google Scholar]
  2. Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol 2015; 42:77–103 [View Article] [PubMed]
     [Google Scholar]
  3. Arora N, Sadovsky Y, Dermody TS, Coyne CB. Microbial vertical transmission during human pregnancy. Cell Host Microbe 2017; 21:561–567 [View Article] [PubMed]
     [Google Scholar]
  4. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26:86–102 [View Article] [PubMed]
     [Google Scholar]
  5. de Jong EP, Vossen A, Walther FJ, Lopriore E. How to use neonatal TORCH testing. Arch Dis Child Educ Pract Ed 2013; 98:93–98 [View Article] [PubMed]
     [Google Scholar]
  6. Ades AE. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 1992; 108:367–375 [View Article] [PubMed]
     [Google Scholar]
  7. Gaytant MA, Galama JMD, Semmekrot BA, Melchers WJG, Sporken JMM et al. The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 2005; 76:71–75 [View Article] [PubMed]
     [Google Scholar]
  8. Konikkara KP, Manjiyil IJ, Narayanan VA, Kannambra PN. Seroprevalence of TORCH infections in pregnant women attending antenatal clinic in a tertiary care hospital. JEMDS 2019; 8:2958–2962 [View Article]
     [Google Scholar]
  9. De Paschale M, Agrappi C, Clerici P, Mirri P, Manco MT et al. Seroprevalence and incidence of toxoplasma gondii infection in the legnano area of Italy. Clin Microbiol Infect 2008; 14:186–189 [View Article] [PubMed]
     [Google Scholar]
  10. Pinto B, Castagna B, Mattei R, Bruzzi R, Chiumiento L et al. Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy. Eur J Clin Microbiol Infect Dis 2012; 31:1151–1156 [View Article] [PubMed]
     [Google Scholar]
  11. Fanigliulo D, Marchi S, Montomoli E, Trombetta CM. Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in central and Southern Italy from 2013 to 2017. Parasite 2020; 27:2 [View Article] [PubMed]
     [Google Scholar]
  12. Saso A, Bamford A, Grewal K, Noori M, Hatcher J et al. Fifteen-minute consultation: management of the infant born to a mother with toxoplasmosis in pregnancy. Arch Dis Child Educ Pract Ed 2020; 105:262–269 [View Article] [PubMed]
     [Google Scholar]
  13. Hoehl S, Berger A, Ciesek S, Rabenau HF. Thirty years of CMV seroprevalence-a longitudinal analysis in a German university hospital. Eur J Clin Microbiol Infect Dis 2020; 39:1095–1102 [View Article] [PubMed]
     [Google Scholar]
  14. Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M et al. Seroprevalence of TORCH infections in women of childbearing age in Croatia. J Matern Fetal Neonatal Med 2011; 24:280–283 [View Article] [PubMed]
     [Google Scholar]
  15. Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC et al. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet 2012; 116:211–213 [View Article] [PubMed]
     [Google Scholar]
  16. Byrne L, Brant L, Reynolds C, Ramsay M. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS blood and transplant: 2004-2009. Is rubella susceptibility increasing?. Vaccine 2012; 30:161–167 [View Article] [PubMed]
     [Google Scholar]
  17. Gorun F, Malita D, Ciohat I, Vilibic-Cavlek T, Feier H et al. Prevalence of rubella antibodies among fertile women in the West of Romania, 18 years after the implementation of immunization. Vaccines 2021; 9:104 [View Article] [PubMed]
     [Google Scholar]
  18. Ramos JM, Milla A, Rodríguez JC, Gutiérrez F. Rubella immune status among immigrant and nonimmigrant women in Spain. J Med Virol 2012; 84:548–550 [View Article] [PubMed]
     [Google Scholar]
  19. Marchi S, Viviani S, Montomoli E, Trombetta CM. Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Hum Vaccin Immunother 2020; 16:895–898 [View Article] [PubMed]
     [Google Scholar]
  20. Adamo G, Baccolini V, Massimi A, Barbato D, Cocchiara R et al. Towards elimination of measles and rubella in Italy: progress and challenges. PLoS One 2019; 14:e0226513 [View Article] [PubMed]
     [Google Scholar]
  21. Korenromp EL, Mahiané SG, Nagelkerke N, Taylor MM, Williams R et al. Syphilis prevalence trends in adult women in 132 countries - estimations using the spectrum sexually transmitted infections model. Sci Rep 2018; 8:11503 [View Article] [PubMed]
     [Google Scholar]
  22. Marangoni A, Moroni A, Tridapalli E, Capretti MG, Farneti G et al. Antenatal syphilis serology in pregnant women and follow-up of their infants in northern Italy. Clin Microbiol Infect 2008; 14:1065–1068 [View Article] [PubMed]
     [Google Scholar]
  23. Tridapalli E, Capretti MG, Reggiani MLB, Stronati M, Faldella G. The Italian neonatal task force of congenital syphilis for the Italian society of neonatology – collaborative group. congenital syphilis in Italy: a multicentre study. Arch Dis Child Fetal Neonatal Ed 2012; 97:F211–F213 [View Article]
     [Google Scholar]
  24. Balla E, Donders GGG. Features of syphilis seropositive pregnant women raising alarms in Hungary, 2013-2016. Eur J Obstet Gynecol Reprod Biol 2018; 228:274–278 [View Article] [PubMed]
     [Google Scholar]
  25. De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A et al. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol 2012; 2012:430585 [View Article] [PubMed]
     [Google Scholar]
  26. Puccio G, Cajozzo C, Canduscio LA, Cino L, Romano A et al. Epidemiology of toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population. Ital J Pediatr 2014; 40:23 [View Article] [PubMed]
     [Google Scholar]
  27. Trombetta CM, Viviani S, Montomoli E, Marchi S. Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy). J Prev Med Hyg 2021; 62:E372–E376 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001733
Loading
Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012–2022) in Italy
J. Med. Microbiol. 72, 001733 (2023); https://doi.org/10.1099/jmm.0.001733
/content/journal/jmm/10.1099/jmm.0.001733
/content/journal/jmm/10.1099/jmm.0.001733
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error